A Study of Fluzoparib±Apatinib Versus Placebo Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on First-Line Platinum-Based Chemotherapy
Clinical trial NCT04229615 · UNKNOWN
Trial details
- NCT number
- NCT04229615
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-02
- Primary completion
- 2023-06-30
- Enrollment
- 690
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.